Reduced release of DNA from streptococcus pneumoniae after treatment with rifampin in comparison to spontaneous growth and ceftriaxone treatment.
In order to study the release of DNA from Streptococcus pneumoniae in vitro during spontaneous growth and treatment with ceftriaxone or rifampin, a semiquantitative polymerase chain reaction was used. During spontaneous growth, high concentrations of bacterial DNA were released. Exposure to 10 microg/ml of ceftriaxone decreased the DNA release, in median, by 19 times (P=0.03 vs. spontaneous growth). Treatment with 10 microg/ml of rifampin led to a reduction of DNA release, in median, by a factor of 49 (P=0.03 vs. ceftriaxone; six experiments performed on different days).
Gerber
J
J
Department of Neurology, University of Gottingen, Germany.
Eiffert
H
H
Fleischer
H
H
Wellmer
A
A
Munzel
U
U
Nau
R
R
D001483:Base Sequence; D002443:Ceftriaxone / Q000494:pharmacology*; D004269:DNA, Bacterial / Q000032:analysis* / Q000187:drug effects*; D006801:Humans; D007124:Immunoenzyme Techniques; D008969:Molecular Sequence Data; D016133:Polymerase Chain Reaction; D011336:Probability; D012016:Reference Values; D012293:Rifampin / Q000494:pharmacology*; D012680:Sensitivity and Specificity; D013296:Streptococcus pneumoniae / Q000187:drug effects* / Q000254:growth & development*
D004269:DNA, Bacterial; D002443:Ceftriaxone; D012293:Rifampin